Further, we have discovered that MIR190A is an ATG7 upstream positive regulator for ATG7 overexpression, whereas ARHGDIB is the ATG7 downstream effector and is responsible for promoting BC invasion. This evidence concerns the gene ARHGDIB and breast cancer.